On the Inhibition of Lipid Peroxidation and Ferroptosis by Fatty Acids
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.6c00583 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Melodie Mallais und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ONK1N 6N5, Canada. Hauptthemen laut MEDLINE: Lipid Peroxidation, Ferroptosis, Fatty Acids. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Canada Foundation for Innovation, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Most inhibitors of lipid peroxidation (LPO) and associated ferroptosis are small molecules that trap LPO-propagating radicals. Among the handful of other inhibitors are select fatty acids: monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids substituted with deuterium atoms at their reactive bis-allylic positions (D-PUFAs), which render them significantly less reactive to LPO-propagating radicals. To probe whether the simple replacement of oxidizable PUFAs with non-oxidizable FAs is a general strategy for ferroptosis suppression, we prepared derivatives of representative PUFAs—linoleic acid (LA) and arachidonic acid (AA)—with cyclopropane rings in place of their unsaturations (CP-PUFAs). Cyclopropanation was predicted to boost the strength of the neighboring C–H bonds by ∼20 kcal/mol and increase the barrier to reaction with peroxyl radicals by ∼104-fold while preserving their cis geometry. CP-PUFAs suppressed ferroptosis induced by erastin2 in HT-1080 cells and RSL3 in HEK-293 cells, similarly to D-PUFAs and MUFAs. Palmitate, a representative endogenous saturated FA, did not suppress ferroptosis. Whereas d6-AA was more effective than d2-LA, the opposite was true of the CP-PUFAs, with CP4-AA possessing only modest activity while CP2-LA was comparable to the D-PUFAs. Lipidomics provides evidence for more extensive lipid remodeling upon treatment with CP2-LA relative to CP4-AA, with PUFAs being enriched in triacylglycerols at the expense of the diacylglycerols used for phospholipid synthesis. Overall, these results suggest that replacement of oxidizable PUFAs with non-oxidizable FAs is a general strategy to suppress ferroptosis—provided that the non-oxidizable FA can be utilized by the biosynthetic machinery and is not lipotoxic at concentrations necessary for protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ONK1N 6N5, Canada.
- Department of Biology, Stanford University, Stanford, California94305, United States.
- Institut des Biomolecules Max Mousseron, Universitet de Montpellier, CNRS, École Nationale Supérieure De Chimie De Montpellier, Montpellier34296, France.
- Department of Environmental and Occupational Health, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania15260, United States.
ORCID-Profile: Scott J Dixon, Derek A Pratt
Förderung
- NIGMS NIH HHS
- Canada Foundation for Innovation
- National Institute of General Medical Sciences
- Government of Ontario
- Natural Sciences and Engineering Research Council of Canada (NSERC)
Zitieren
APA
Mallais, M., Szylo, K., Magtanong, L., Shchepinov, M. S., Dixon, S. J., & Pratt, D. A. (2026). On the Inhibition of Lipid Peroxidation and Ferroptosis by Fatty Acids. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00583
Vancouver
Mallais M, Szylo K, Magtanong L, Shchepinov MS, Dixon SJ, Pratt DA. On the Inhibition of Lipid Peroxidation and Ferroptosis by Fatty Acids. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00583
BibTeX
@article{Mallais2026,
author = {Mallais, Melodie and Szylo, Krystina and Magtanong, Leslie and Shchepinov, Mikhail S and Dixon, Scott J and Pratt, Derek A},
title = {On the Inhibition of Lipid Peroxidation and Ferroptosis by Fatty Acids},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00583}
}
EUVIMED